US FDA accepts new drug application filed by Avillion for AstraZeneca's PT027
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services
Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
Each member of Fitelo's team of experts gives highly personalized attention and recommendations to their clients ensuring they reach their fitness goals holis
The key categories include intimate wellness, skincare & hair care
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
Acute asthma attack is a common cause of admission to emergency departments (EDs) among children, and triage by severity is important for determining appropriate clinical treatment
Dxcover announced that it will be presenting new data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 3-7
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
Subscribe To Our Newsletter & Stay Updated